JSA Advocates and Solicitors has completed the onboarding of Equity Partners Iqbal Khan and Ambarish, along with their distinguished team of 18 lawyers, including three Retained Partners, from Shardul Amarchand Mangaldas & Co (SAM). Khan joined as the National Corporate Lead. Khan and Ambarish boast of an impressive track record, having led landmark transactions for prominent clients, such as Advent, Bain, Brookefield, TPG, Biocon, L&T, LIC, PharmEasy, Reliance, Serum and TATA, among others. Khan’s exceptional expertise in handling large, complex private equity and M&A transactions — spanning listed, unlisted and cross-border deals — has earned him a sterling reputation in the legal fraternity. Prior to his tenure at SAM, he was with Paul Weiss and Kirkland & Ellis in the US. A member of the Bar Council of Maharashtra & Goa and the New York Bar, Khan holds JD from Columbia Law School (Harlan Fisk Stone Scholar), Parker School Certificate for Achievement in International and Comparative Law and LLB from the London School of Economics and Political Science. In addition, Khan has been the Editor of the Columbia Journal of European Law. Ambarish brings with him 16 years of extensive experience at both SAM and the erstwhile Amarchand. His specialization in private and public M&A transactions, and matters involving SEBI, listed companies and corporate governance, along with his significant practice in Japan, makes him a strategic addition to JSA. He is highly regarded for his adept handling of some of the largest M&A and private equity transactions in India, representing both foreign and Indian majors. Ambarish has also been involved in assisting the government in drafting several key regulations. A member of the Bar Council of Delhi, he holds BBA LLB (Honours) from National Law University, Jodhpur.
